CCCC
Price
$1.62
Change
+$0.10 (+6.58%)
Updated
Jun 12 closing price
Capitalization
107.93M
54 days until earnings call
MLTX
Price
$44.02
Change
-$0.15 (-0.34%)
Updated
Jun 12 closing price
Capitalization
2.79B
55 days until earnings call
Interact to see
Advertisement

CCCC vs MLTX

Header iconCCCC vs MLTX Comparison
Open Charts CCCC vs MLTXBanner chart's image
C4 Therapeutics
Price$1.62
Change+$0.10 (+6.58%)
Volume$1.22M
Capitalization107.93M
MoonLake Immunotherapeutics
Price$44.02
Change-$0.15 (-0.34%)
Volume$820K
Capitalization2.79B
CCCC vs MLTX Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. MLTX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (CCCC: $1.62 vs. MLTX: $44.02)
Brand notoriety: CCCC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 107% vs. MLTX: 153%
Market capitalization -- CCCC: $107.93M vs. MLTX: $2.79B
CCCC [@Biotechnology] is valued at $107.93M. MLTX’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +10.20% price change this week, while MLTX (@Biotechnology) price change was -9.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.74%. For the same industry, the average monthly price growth was +15.53%, and the average quarterly price growth was +6.63%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.79B) has a higher market cap than CCCC($108M). MLTX YTD gains are higher at: -18.707 vs. CCCC (-55.000). CCCC has higher annual earnings (EBITDA): -102.74M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. CCCC (215M). MLTX has less debt than CCCC: MLTX (2.83M) vs CCCC (64.4M). CCCC has higher revenues than MLTX: CCCC (39.8M) vs MLTX (0).
CCCCMLTXCCCC / MLTX
Capitalization108M2.79B4%
EBITDA-102.74M-141.71M73%
Gain YTD-55.000-18.707294%
P/E RatioN/AN/A-
Revenue39.8M0-
Total Cash215M448M48%
Total Debt64.4M2.83M2,276%
TECHNICAL ANALYSIS
Technical Analysis
CCCCMLTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLGRX84.72N/A
N/A
JPMorgan Large Cap Growth R5
FACSX49.57N/A
N/A
Nuveen Mid Cap Value 1 C
PJARX10.12N/A
N/A
Principal SmallCap Value II R3
BRKCX15.52N/A
N/A
MFS Blended Research Em Mkts Eq C
BEXUX17.39N/A
N/A
Baron Emerging Markets R6

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with CRBU. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+6.58%
CRBU - CCCC
57%
Loosely correlated
-1.69%
KYMR - CCCC
56%
Loosely correlated
-2.27%
BEAM - CCCC
54%
Loosely correlated
-2.52%
PRME - CCCC
53%
Loosely correlated
-4.58%
FATE - CCCC
53%
Loosely correlated
-9.68%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-0.34%
XENE - MLTX
45%
Loosely correlated
+1.67%
XNCR - MLTX
45%
Loosely correlated
-0.95%
IDYA - MLTX
43%
Loosely correlated
+1.64%
CLDX - MLTX
42%
Loosely correlated
-0.34%
DNLI - MLTX
42%
Loosely correlated
-1.74%
More